These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 6878294)

  • 21. Community-based breast health partnerships.
    True SJ
    J Public Health Manag Pract; 1995; 1(3):67-72. PubMed ID: 10186625
    [TBL] [Abstract][Full Text] [Related]  

  • 22. "Health is strength": a community health education program to improve breast and cervical cancer screening among Korean American Women in Alameda County, California.
    Moskowitz JM; Kazinets G; Wong JM; Tager IB
    Cancer Detect Prev; 2007; 31(2):173-83. PubMed ID: 17418978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Special Surveillance Breast Program: a model of intervention for women at high risk for breast cancer.
    Gross RE; Van Zee KJ; Heerdt AS
    J N Y State Nurses Assoc; 1997 Dec; 28(4):9-12. PubMed ID: 9564357
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of estrogen receptor data: recommendations for Iowa.
    Corder MP; Caughlan CR; Clark GR; Culp DA; Guthrie RT; Hass AC; Hoak JC; Jochimsen PR; Ketelaar RJ; Leafstedt SW; Maher LL; Wilmarth CB
    J Iowa Med Soc; 1980 Mar; 70(3):105-8. PubMed ID: 7365288
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Recommendations for the immunohistochemistry of the hormonal receptors on paraffin sections in breast cancer. Update 1999. Group for Evaluation of Prognostic Factors using Immunohistochemistry in Breast Cancer (GEFPICS-FNCLCC)].
    Ann Pathol; 1999 Sep; 19(4):336-43. PubMed ID: 10544774
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The public health breast and cervical cancer program. Our role as physicians.
    Allaben R; Boorstein R; Youngs B
    Mich Med; 1993 Mar; 92(3):16-20. PubMed ID: 8231908
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Breast cancer in limited-resource countries: health care systems and public policy.
    Anderson BO; Yip CH; Ramsey SD; Bengoa R; Braun S; Fitch M; Groot M; Sancho-Garnier H; Tsu VD;
    Breast J; 2006; 12 Suppl 1():S54-69. PubMed ID: 16430399
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of a pilot study for breast and cervical cancer screening with Bradford's minority ethnic women; a community development approach, 1991-93.
    Kernohan EE
    Br J Cancer Suppl; 1996 Sep; 29():S42-6. PubMed ID: 8782798
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma enterolactone and breast cancer incidence by estrogen receptor status.
    Olsen A; Knudsen KE; Thomsen BL; Loft S; Stripp C; Overvad K; Møller S; Tjønneland A
    Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2084-9. PubMed ID: 15598765
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical research on estrogen receptors of breast cancer and endocrine therapy].
    Song ST; Tang ZM
    Zhonghua Zhong Liu Za Zhi; 1993 Mar; 15(2):83-5. PubMed ID: 8223130
    [No Abstract]   [Full Text] [Related]  

  • 31. Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975-1999.
    Mariotto AB; Feuer EJ; Harlan LC; Abrams J
    J Natl Cancer Inst Monogr; 2006; (36):7-15. PubMed ID: 17032888
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oncology nursing in the small community hospital.
    Haylock PJ
    Oncology (Williston Park); 1993 Sep; 7(9):73-8; discussion 80-2, 89. PubMed ID: 8217532
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The National Breast and Cervical Cancer Early Detection Program: a comprehensive public health response to two major health issues for women.
    Henson RM; Wyatt SW; Lee NC
    J Public Health Manag Pract; 1996; 2(2):36-47. PubMed ID: 10186667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evolution of multiple disease screening in Keelung: a model for community involvement in health interventions?
    Wang PE; Wang TT; Chiu YH; Yen AM; Chen TH
    J Med Screen; 2006; 13 Suppl 1():S54-8. PubMed ID: 17227644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical factors related to the presence of estrogen receptors in breast cancer: a prognostic stratification analysis.
    Pascual MR; Lazo R; Fernandez L; Lage A
    Neoplasma; 1982; 29(4):453-61. PubMed ID: 7133236
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical significance of steroid receptors in breast cancer].
    Svastics E; Számel I; Ringwald G; Vincze B; Besznyák I; Tóth J
    Orv Hetil; 1994 Mar; 135(10):513-7. PubMed ID: 8146006
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study.
    Fisher B; Costantino JP; Wickerham DL; Cecchini RS; Cronin WM; Robidoux A; Bevers TB; Kavanah MT; Atkins JN; Margolese RG; Runowicz CD; James JM; Ford LG; Wolmark N
    J Natl Cancer Inst; 2005 Nov; 97(22):1652-62. PubMed ID: 16288118
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sex steroid receptors in gynecologic cancer.
    Hoffman PG; Siiteri PK
    Obstet Gynecol; 1980 May; 55(5):648-52. PubMed ID: 6988749
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Breast cancer--screening data for assessing quality of services--New York, 2000-2003.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2004 Jun; 53(21):455-7. PubMed ID: 15175570
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The development of a community breast center.
    Ward SJ; Edge RM; Peterson C
    J Oncol Manag; 1999; 8(3):10-2. PubMed ID: 10538237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.